VTAK (Catheter Precision) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VTAK Catheter Precision Inc VTAK
23 GF Score
Price $0.56
GF Value $1.70
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Catheter Precision FFO per Share?

FFO per Share only applies to REITs.

VTAK
23GF Score
Catheter Precision Inc VTAK
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Catheter Precision (VTAK) Overvalued in 2026?

Based on GuruFocus' analysis, Catheter Precision stock appears to be undervalued. The current stock price of $0.56 is trading 66.9% below its estimated GF Value™ of $1.70. GuruFocus considers Catheter Precision to be Possible Value Trap.

Key valuation signals for VTAK:

  • FFO per Share:
  • GF Value™: $1.70 vs. price of $0.56 (66.9% below fair value)
  • GF Score™: 23/100 with 7 warning signs

No single metric tells the full story. See the VTAK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Catheter Precision Business Description

Address 1670 Highway 160 West, Suite 205, Fort Mill, SC, USA, 29708
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
23GF Score

Get the complete analysis for VTAK

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.56
Price
$1.70
GF Value